チェルノブイリ事故から15年:甲状腺がんの新たな証拠
Lancet (London, England)
|December 19, 2001
まとめ
1986年のチェルノブイリ事故は,放射性降下物にさらされた子供たちの間で甲状腺がんの有意な増加を引き起こしました. 事故前に生まれた子供は,事故後の甲状腺癌の発生率が高かった.
科学分野:
- 環境衛生 環境衛生 環境衛生
- 核医学は,核医学である.
- 小児腫瘍学 小児腫瘍学
背景:
- チェルノブイリ原子力発電所の事故は,1986年4月26日に発生し,広範囲にわたる放射性汚染を引き起こしました.
- この研究は,チェルノブイリ事故の半径150km以内に住む子供たちの甲状腺がんの発生率を調査し,事故前と事故後に生まれた子供たちを比較しています.
関連する概念動画
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


